For research use only. Not for therapeutic Use.
CB-25(CAT: R033070) is a selective ligand of the CB1 cannabinoid receptor, acting as a partial agonist. It enhances Forskolin-induced cAMP formation in cancer cells, providing a potential therapeutic strategy in oncology. Unlike in hCB1-CHO cells, CB-25 specifically modulates intracellular signaling pathways in cancer cells, suggesting its selective action in tumor microenvironments. This compound may offer novel insights into cancer cell biology by manipulating cannabinoid receptor pathways to affect cellular processes like growth and survival. CB-25 is an emerging candidate in Cancer Disease Research, offering a targeted approach to modulate cancer cell signaling.
| CAS Number | 869376-63-6 |
| Synonyms | N-cyclopropyl-11-(3-hydroxy-5-pentylphenoxy)undecanamide |
| Molecular Formula | C25H41NO3 |
| Purity | ≥95% |
| IUPAC Name | N-cyclopropyl-11-(3-hydroxy-5-pentylphenoxy)undecanamide |
| InChI | InChI=1S/C25H41NO3/c1-2-3-10-13-21-18-23(27)20-24(19-21)29-17-12-9-7-5-4-6-8-11-14-25(28)26-22-15-16-22/h18-20,22,27H,2-17H2,1H3,(H,26,28) |
| InChIKey | XFHZHCKWTBGPFD-UHFFFAOYSA-N |
| SMILES | CCCCCC1=CC(=CC(=C1)OCCCCCCCCCCC(=O)NC2CC2)O |
| Chemistry Calculators | Dilution Calculator In vivo Formulation Calculator Molarity Calculator Molecular Weight Calculator Reconstitution Calculator |
